annual CAPEX:
$725.00K+$174.00K(+31.58%)Summary
- As of today (June 3, 2025), SUPN annual capital expenditures is $725.00 thousand, with the most recent change of +$174.00 thousand (+31.58%) on December 31, 2024.
- During the last 3 years, SUPN annual CAPEX has fallen by -$1.32 million (-64.55%).
- SUPN annual CAPEX is now -80.35% below its all-time high of $3.69 million, reached on December 31, 2020.
Performance
SUPN CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$327.00K+$114.00K(+53.52%)Summary
- As of today (June 3, 2025), SUPN quarterly capital expenditures is $327.00 thousand, with the most recent change of +$114.00 thousand (+53.52%) on March 31, 2025.
- Over the past year, SUPN quarterly CAPEX has increased by +$79.00 thousand (+31.85%).
- SUPN quarterly CAPEX is now -87.11% below its all-time high of $2.54 million, reached on March 31, 2020.
Performance
SUPN quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$804.00K+$79.00K(+10.90%)Summary
- As of today (June 3, 2025), SUPN TTM capital expenditures is $804.00 thousand, with the most recent change of +$79.00 thousand (+10.90%) on March 31, 2025.
- Over the past year, SUPN TTM CAPEX has increased by +$283.00 thousand (+54.32%).
- SUPN TTM CAPEX is now -80.92% below its all-time high of $4.21 million, reached on June 30, 2020.
Performance
SUPN TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
SUPN CAPEX Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +31.6% | +31.9% | +54.3% |
3 y3 years | -64.5% | -61.6% | -14.0% |
5 y5 years | -47.7% | -87.1% | -78.3% |
SUPN CAPEX Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -64.5% | +76.0% | -61.6% | +156.8% | -14.0% | +599.4% |
5 y | 5-year | -80.3% | +76.0% | -87.1% | +156.8% | -80.9% | +599.4% |
alltime | all time | -80.3% | +437.0% | -87.1% | +156.8% | -80.9% | +599.4% |
SUPN CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $327.00K(+53.5%) | $804.00K(+10.9%) |
Dec 2024 | $725.00K(+31.6%) | $213.00K(+6.5%) | $725.00K(+52.3%) |
Sep 2024 | - | $200.00K(+212.5%) | $476.00K(+11.7%) |
Jun 2024 | - | $64.00K(-74.2%) | $426.00K(-18.2%) |
Mar 2024 | - | $248.00K(-788.9%) | $521.00K(-5.4%) |
Dec 2023 | $551.00K(+33.7%) | -$36.00K(-124.0%) | $551.00K(-4.5%) |
Sep 2023 | - | $150.00K(-5.7%) | $577.00K(+0.5%) |
Jun 2023 | - | $159.00K(-42.8%) | $574.00K(-456.5%) |
Mar 2023 | - | $278.00K(-2880.0%) | -$161.00K(-139.1%) |
Dec 2022 | $412.00K(-79.9%) | -$10.00K(-106.8%) | $412.00K(-10.8%) |
Sep 2022 | - | $147.00K(-125.5%) | $462.00K(+28.7%) |
Jun 2022 | - | -$576.00K(-167.7%) | $359.00K(-61.6%) |
Mar 2022 | - | $851.00K(+2027.5%) | $935.00K(-54.3%) |
Dec 2021 | $2.04M(-44.6%) | $40.00K(-9.1%) | $2.04M(-11.9%) |
Sep 2021 | - | $44.00K(>+9900.0%) | $2.32M(-10.0%) |
Jun 2021 | - | $0.00(-100.0%) | $2.58M(-17.2%) |
Mar 2021 | - | $1.96M(+522.5%) | $3.11M(-15.6%) |
Dec 2020 | $3.69M(+166.0%) | $315.00K(+4.0%) | $3.69M(-9.0%) |
Sep 2020 | - | $303.00K(-43.4%) | $4.05M(-3.8%) |
Jun 2020 | - | $535.00K(-78.9%) | $4.21M(+13.8%) |
Mar 2020 | - | $2.54M(+273.1%) | $3.70M(+167.0%) |
Dec 2019 | $1.39M(+64.3%) | $680.00K(+47.2%) | $1.39M(+72.7%) |
Sep 2019 | - | $462.00K(+1825.0%) | $803.00K(+50.9%) |
Jun 2019 | - | $24.00K(-89.1%) | $532.00K(-34.5%) |
Mar 2019 | - | $221.00K(+130.2%) | $812.00K(-3.8%) |
Dec 2018 | $844.00K(-58.4%) | $96.00K(-49.7%) | $844.00K(-43.9%) |
Sep 2018 | - | $191.00K(-37.2%) | $1.50M(-13.3%) |
Jun 2018 | - | $304.00K(+20.2%) | $1.73M(-12.5%) |
Mar 2018 | - | $253.00K(-66.5%) | $1.98M(-2.3%) |
Dec 2017 | $2.03M | $756.00K(+79.6%) | $2.03M(+28.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2017 | - | $421.00K(-23.7%) | $1.57M(+1.4%) |
Jun 2017 | - | $552.00K(+84.0%) | $1.55M(-4.4%) |
Mar 2017 | - | $300.00K(-0.3%) | $1.62M(+1.3%) |
Dec 2016 | $1.60M(-23.8%) | $301.00K(-24.6%) | $1.60M(-26.0%) |
Sep 2016 | - | $399.00K(-36.1%) | $2.17M(-2.9%) |
Jun 2016 | - | $624.00K(+123.7%) | $2.23M(+1.6%) |
Mar 2016 | - | $279.00K(-67.7%) | $2.19M(+4.3%) |
Dec 2015 | $2.10M(+254.8%) | $864.00K(+86.6%) | $2.10M(+54.9%) |
Sep 2015 | - | $463.00K(-21.3%) | $1.36M(+37.3%) |
Jun 2015 | - | $588.00K(+211.1%) | $989.00K(+90.6%) |
Mar 2015 | - | $189.00K(+60.2%) | $519.00K(-12.5%) |
Dec 2014 | $593.00K(-64.0%) | $118.00K(+25.5%) | $593.00K(+47.9%) |
Sep 2014 | - | $94.00K(-20.3%) | $401.00K(-59.5%) |
Jun 2014 | - | $118.00K(-55.1%) | $990.00K(-35.6%) |
Mar 2014 | - | $263.00K(-455.4%) | $1.54M(-6.6%) |
Dec 2013 | $1.65M(+118.6%) | -$74.00K(-110.8%) | $1.65M(-14.3%) |
Sep 2013 | - | $683.00K(+2.7%) | $1.92M(+17.8%) |
Jun 2013 | - | $665.00K(+78.8%) | $1.63M(+50.2%) |
Mar 2013 | - | $372.00K(+86.0%) | $1.08M(+44.1%) |
Dec 2012 | $753.00K(+9.9%) | $200.00K(-49.1%) | $753.00K(+1.2%) |
Sep 2012 | - | $393.00K(+227.5%) | $744.00K(+73.4%) |
Jun 2012 | - | $120.00K(+200.0%) | $429.00K(-17.8%) |
Mar 2012 | - | $40.00K(-79.1%) | $522.00K(-23.8%) |
Dec 2011 | $685.00K(+133.0%) | $191.00K(+144.9%) | $685.00K(+38.7%) |
Sep 2011 | - | $78.00K(-63.4%) | $494.00K(+18.8%) |
Jun 2011 | - | $213.00K(+4.9%) | $416.00K(+104.9%) |
Mar 2011 | - | $203.00K | $203.00K |
Dec 2010 | $294.00K(-58.8%) | - | - |
Dec 2009 | $714.00K(+428.9%) | - | - |
Dec 2008 | $135.00K(-87.3%) | - | - |
Dec 2007 | $1.06M | - | - |
FAQ
- What is Supernus Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals annual CAPEX year-on-year change?
- What is Supernus Pharmaceuticals quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals quarterly CAPEX year-on-year change?
- What is Supernus Pharmaceuticals TTM capital expenditures?
- What is the all time high TTM CAPEX for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals TTM CAPEX year-on-year change?
What is Supernus Pharmaceuticals annual capital expenditures?
The current annual CAPEX of SUPN is $725.00K
What is the all time high annual CAPEX for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high annual capital expenditures is $3.69M
What is Supernus Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, SUPN annual capital expenditures has changed by +$174.00K (+31.58%)
What is Supernus Pharmaceuticals quarterly capital expenditures?
The current quarterly CAPEX of SUPN is $327.00K
What is the all time high quarterly CAPEX for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high quarterly capital expenditures is $2.54M
What is Supernus Pharmaceuticals quarterly CAPEX year-on-year change?
Over the past year, SUPN quarterly capital expenditures has changed by +$79.00K (+31.85%)
What is Supernus Pharmaceuticals TTM capital expenditures?
The current TTM CAPEX of SUPN is $804.00K
What is the all time high TTM CAPEX for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high TTM capital expenditures is $4.21M
What is Supernus Pharmaceuticals TTM CAPEX year-on-year change?
Over the past year, SUPN TTM capital expenditures has changed by +$283.00K (+54.32%)